Table 3.
Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C, with and without human immunodeficiency virus
| HIV | n | HCC | % | Patient-years | Rate × 100 patient-years | RR | 95%CI | P value |
| + | 399 | 10 | 2.5 | 3963.80 | 0.25 | - | - | - |
| - | 405 | 26 | 6.4 | 3624.50 | 0.72 | 2.98 | 1.43-6.18 | 0.003 |
| Model 2: adjusted for age | 1.29 | 0.58-2.87 | 0.529 | |||||
| Model 3: adjusted for age and DM | 1.27 | 0.56-2.88 | 0.571 | |||||
| Model 4: adjusted for age, DM and alcohol | 1.23 | 0.52-2.95 | 0.638 | |||||
HIV: Human immunodeficiency virus; HCC: Hepatocellular carcinoma; RR: Rate ratio; DM: Diabetes mellitus.